(RTTNews) - Humacyte, Inc. (HUMA) on Thursday said it plans to file an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) in the fourth quarter for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results